ARTV Artiva Biotherapeutics, Inc. - Common Stock
$11.32
Price · Aug 19, 2026
Fundamentals as of Aug 6, 2026
52W Range
$2–$15
74% of range
Analyst Rating
BUY
12 analysts
Price Target
$36
+216% upside
P/E (TTM)
-1.3
ROE
—
Net Profit Margin
—
ARTV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$11.32
Market Cap
—
P/E (TTM)
-1.3
EPS (TTM)
$-3.43
Revenue (TTM)
$0
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$2 – $15
ARTV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$0
2023-12-31
→
2025-12-31
EPS
$-3.43
2023-12-31
→
2025-12-31
Free Cash Flow
—
2024-12-31
→
2024-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ARTV
Peer Median
P/E (TTM)
-1.3
19.6
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ARTV
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ARTV
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ARTV
Peer Median
Revenue YoY
-99.2%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ARTV
Peer Median
ARTV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
12 analysts
- Strong Buy 4 33.3%
- Buy 7 58.3%
- Hold 1 8.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
5 analysts · 2026-08-18
Median
$40.00
Mean
$35.80
← Below all targets
$11.32
Low
$23.00
High
$41.00
Median target
$40.00
+253.4%
Mean target
$35.80
+216.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.01%
Next Report
Aug 27, 2026
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.63 | $-0.64 | 0.01% |
| March 31, 2026 | $-0.95 | $-0.89 | -0.06% |
| Dec. 31, 2025 | $-0.85 | $-0.84 | -0.01% |
| Sept. 30, 2025 | $-0.88 | $-0.89 | 0.01% |
| June 30, 2025 | $-0.87 | $-0.82 | -0.05% |
| March 31, 2025 | $-0.83 | $-0.72 | -0.11% |
| Dec. 31, 2024 | $-0.66 | $-0.77 | 0.11% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ARTV | — | -1.3 | -99.2% | — | — | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| EIKN | — | — | — | — | — | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $251.0K | $33M | |
| R&D Expense | $70M | $50M | $50M | |
| SG&A Expense | $20M | $17M | $14M | |
| Operating Expenses | $90M | $68M | $64M | |
| Operating Income | $-90M | $-67M | $-31M | |
| Other Non-op | $-14.0K | $157.0K | $195.0K | |
| Pretax Income | · | $-65M | $-29M | |
| Income Tax | $0 | $0 | $72.0K | |
| Net Income | $-84M | $-65M | $-29M | |
| EPS (Basic) | $-3.43 | $-5.81 | $-35.78 | |
| EPS (Diluted) | $-3.43 | $-5.81 | $-35.78 | |
| Shares (Basic) | 24,444,057 | 11,258,851 | 802,747 | |
| Shares (Diluted) | 24,444,057 | 11,258,851 | 802,747 | |
| EBITDA | · | $-65M | · |
Balance Sheet 22
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $40M | $54M | |
| Short-term Investments | $81M | $145M | $23M | |
| Receivables | · | $0 | $1M | |
| Prepaid Expense | $5M | $3M | $1M | |
| Current Assets | $113M | $189M | $80M | |
| PP&E (Net) | $7M | $6M | $8M | |
| PP&E (Gross) | $15M | $12M | $12M | |
| Accum. Depreciation | $8M | $6M | $4M | |
| Other Non-current Assets | $458.0K | $267.0K | $392.0K | |
| Total Assets | $131M | $210M | $105M | |
| Accounts Payable | $355.0K | $1M | $614.0K | |
| Accrued Liabilities | $10M | $7M | $8M | |
| Current Liabilities | $13M | $12M | $12M | |
| Capital Leases | $8M | $11M | $13M | |
| Other Non-current Liabilities | · | $73.0K | $73.0K | |
| Total Liabilities | $21M | $23M | $51M | |
| Common Stock | $3.0K | $3.0K | · | |
| Retained Earnings | $-331M | $-247M | $-181M | |
| AOCI | $103.0K | $-129.0K | $308.0K | |
| Stockholders' Equity | $110M | $187M | $-162M | |
| Liabilities + Equity | $131M | $210M | $105M | |
| Shares Outstanding | 24,595,550 | 24,291,607 | 809,758 |
Cash Flow 11
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $3M | $2M | $2M | |
| Stock-based Comp | $7M | $7M | $7M | |
| Other Non-cash | · | $930.0K | · | |
| Operating Cash Flow | $-77M | $-55M | $-47M | |
| CapEx | $3M | $642.0K | $3M | |
| Investing Cash Flow | $63M | $-120M | $-26M | |
| Stock Issued | $0 | $167M | · | |
| Net Stock Activity | · | $167M | · | |
| Financing Cash Flow | $9.0K | $162M | $24M | |
| Net Change in Cash | $-13M | $-13M | $-49M | |
| Free Cash Flow | · | $-56M | · |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -26805.6% | · | |
| Net Margin | · | -26045.0% | · | |
| Pretax Margin | · | -26045.0% | · | |
| EBITDA Margin | · | -25837.0% | · | |
| ROA | · | -41.5% | · | |
| ROE | · | -33.7% | · | |
| ROIC | · | -36.0% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | · | 15.4 | · | |
| Quick Ratio | · | 15.1 | · |
Efficiency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | |
| Receivables Turnover | · | 0.5 | · |
Growth Rates 1
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | · | -99.2% | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $251.0K | · | |
| Net Income TTM | $-84M | $-65M | · | |
| Market Cap | · | $245M | · | |
| P/E | -1.3 | -1.7 | · | |
| P/S | · | 975.5 | · | |
| P/B | · | 1.3 | · | |
| P / Tangible Book | 0.9 | 1.3 | · | |
| P / Cash Flow | · | -4.4 | · | |
| P / FCF | · | -4.4 | · | |
| Earnings Yield | -80.0% | -57.6% | · |
Income Statement 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $251.0K | $2M | |
| R&D Expense | $22M | $19M | $17M | $18M | $18M | $17M | $13M | $14M | $12M | $11M | $11M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | |
| Operating Expenses | $27M | $24M | $22M | $23M | $23M | $22M | $18M | $18M | $16M | $15M | $14M | |
| Operating Income | $-27M | $-24M | $-22M | $-23M | $-23M | $-22M | $-18M | $-18M | $-16M | $-14M | $-12M | |
| Other Non-op | $-1.0K | $2.0K | $-2.0K | $-3.0K | $-5.0K | $-4.0K | $-7.0K | $-6.0K | $23.0K | $147.0K | $168.0K | |
| Net Income | $-25M | $-24M | $-21M | $-22M | $-21M | $-20M | $-16M | $-17M | $-18M | $-14M | $-12M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| Shares (Basic) | 39,413,236 | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| Shares (Diluted) | 39,413,236 | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| EBITDA | $-27M | $-24M | · | $-23M | $-23M | $-22M | · | $-18M | $-16M | · | · |
Balance Sheet 22
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $301M | $21M | $27M | $26M | $28M | $30M | $40M | $56M | $34M | · | $54M | |
| Short-term Investments | $48M | $66M | $81M | $97M | $114M | $136M | $145M | $91M | $12M | · | $23M | |
| Receivables | · | · | · | · | · | · | · | $569.0K | $569.0K | · | $1M | |
| Prepaid Expense | $3M | $2M | $5M | $6M | $7M | $4M | $3M | $3M | $2M | · | $1M | |
| Current Assets | $352M | $89M | $113M | $130M | $149M | $170M | $189M | $151M | $50M | · | $80M | |
| PP&E (Net) | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $14M | $14M | $12M | $12M | $12M | · | $12M | |
| Accum. Depreciation | $10M | $9M | $8M | $8M | $7M | $7M | $6M | $5M | $5M | · | $4M | |
| Other Non-current Assets | $809.0K | $458.0K | $458.0K | $418.0K | $38.0K | $13.0K | $267.0K | $298.0K | $330.0K | · | $392.0K | |
| Total Assets | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Accounts Payable | $1M | $2M | $355.0K | $848.0K | $1M | $2M | $1M | $1M | $823.0K | · | $614.0K | |
| Accrued Liabilities | $10M | $6M | $10M | $7M | $6M | $6M | $7M | $8M | $6M | · | $8M | |
| Current Liabilities | $15M | $11M | $13M | $11M | $11M | $12M | $12M | $13M | $11M | · | $12M | |
| Capital Leases | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | · | · | · | · | · | · | $73.0K | $73.0K | $74.0K | · | $73.0K | |
| Total Liabilities | $21M | $18M | $21M | $20M | $20M | $22M | $23M | $25M | $51M | · | $51M | |
| Common Stock | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | · | · | |
| Retained Earnings | $-379M | $-354M | $-331M | $-310M | $-288M | $-267M | $-247M | $-231M | $-213M | · | $-181M | |
| AOCI | $-21.0K | $-18.0K | $103.0K | $87.0K | $2.0K | · | $-129.0K | $338.0K | $121.0K | · | $308.0K | |
| Stockholders' Equity | $348M | $88M | $110M | $129M | $149M | $169M | $187M | $201M | $-191M | · | $-162M | |
| Liabilities + Equity | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Shares Outstanding | 48,792,279 | 24,716,672 | 24,291,607 | 24,544,904 | 24,393,524 | 24,363,119 | 24,291,607 | 24,287,144 | 814,202 | · | 809,758 |
Cash Flow 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $692.0K | $666.0K | $666.0K | $662.0K | $641.0K | $628.0K | $614.0K | $627.0K | $603.0K | $587.0K | $594.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $307.0K | · | · | · | $-2M | · | · | · | · | · | |
| Operating Cash Flow | $-20M | $-21M | $-15M | $-19M | $-23M | $-20M | $-15M | $-12M | $-14M | $-15M | $-11M | |
| CapEx | $415.0K | $242.0K | $421.0K | $600.0K | $1M | $511.0K | $64.0K | $96.0K | $464.0K | $18.0K | $636.0K | |
| Investing Cash Flow | $18M | $15M | $16M | $16M | $21M | $10M | $-966.0K | $-131M | $1M | $10M | $-3M | |
| Stock Issued | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $283M | $-112.0K | $-121.0K | $-37.0K | $-72.0K | $239.0K | $-30.0K | $164M | · | · | $962.0K | |
| Net Change in Cash | $280M | $-6M | $1M | $-3M | $-2M | $-10M | $-16M | $22M | $-14M | $-5M | $-12M | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | · | · |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -9.3% | -15.8% | · | -11.5% | -17.3% | -21.2% | · | -15.5% | -47.0% | · | · | |
| ROE | -10.1% | -18.3% | · | -13.0% | 101.1% | -24.1% | · | -17.4% | 18.7% | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.2 | 8.2 | · | 11.6 | 13.8 | 13.9 | · | 11.3 | 4.6 | · | · | |
| Quick Ratio | 24.0 | 8.0 | · | 11.1 | 13.2 | 13.6 | · | 11.1 | 4.4 | · | · |
Valuation (TTM) 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-91M | $-87M | · | $-81M | $-77M | $-70M | · | $-38M | $-32M | · | · | |
| Market Cap | $473M | $159M | · | $70M | $37M | $73M | · | $375M | · | · | · | |
| P/E | -2.9 | -1.8 | · | -0.8 | -0.1 | -0.1 | · | -0.4 | · | · | · | |
| P/B | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Tangible Book | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Cash Flow | · | -7.6 | · | · | · | -3.7 | · | · | · | · | · | |
| P / FCF | · | -7.5 | · | · | · | -3.6 | · | · | · | · | · | |
| Earnings Yield | -34.3% | -54.8% | · | -122.0% | -1630.5% | -1366.3% | · | -249.4% | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Revenue | $0 | $251.0K | $33M |
| Operating Margin % | — | -26805.6% | — |
| Net Income | $-84M | $-65M | $-29M |
| Diluted EPS | $-3.43 | $-5.81 | $-35.78 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Current Ratio | — | 15.4 | — |
| Quick Ratio | — | 15.1 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Free Cash Flow | — | $-56M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 75 filers · $384.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 42 (+32 vs prior Q) | 7 (+2 vs prior Q) | 20 (+19 vs prior Q) | 4 (-8 vs prior Q) | +23.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $174,169,727 | 17,955,642 | 45.32% | Shares |
| VIKING GLOBAL INVESTORS LP | $25,260,410 | 2,604,166 | 6.57% | Shares |
| Blackstone Inc. | $23,313,339 | 2,403,437 | 6.07% | Shares |
| 5AM Venture Management, LLC | $22,827,049 | 2,353,304 | 5.94% | Shares |
| Venrock Adviser, LLC | $19,822,881 | 2,043,596 | 5.16% | Shares |
| FRANKLIN RESOURCES INC | $19,373,063 | 1,997,223 | 5.04% | Shares |
| Caligan Partners LP | $16,840,277 | 1,736,111 | 4.38% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $9,523,606 | 981,815 | 2.48% | Shares |
| SAMSARA BIOCAPITAL, LLC | $9,262,152 | 954,861 | 2.41% | Shares |
| Blue Owl Capital Holdings LP | $8,483,057 | 874,542 | 2.21% | Shares |
| Propel Bio Management, LLC | $6,755,429 | 696,436 | 1.76% | Shares |
| CITADEL ADVISORS LLC | $5,910,947 | 609,376 | 1.54% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $5,092,500 | 525,000 | 1.33% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $3,049,438 | 314,375 | 0.79% | Shares |
| Nantahala Capital Management, LLC | $2,910,000 | 300,000 | 0.76% | Shares |
| Revelation Capital Management, LLC | $2,903,317 | 299,311 | 0.76% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $2,834,361 | 292,032 | 0.74% | Shares |
| Alyeska Investment Group, L.P. | $2,654,066 | 273,615 | 0.69% | Shares |
| ACUTA CAPITAL PARTNERS, LLC | $2,526,035 | 260,416 | 0.66% | Shares |
| KVP Capital Advisors, LP | $1,940,000 | 200,000 | 0.50% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $1,882,848 | 194,108 | 0.49% | Shares |
| UBS Group AG | $1,757,019 | 181,136 | 0.46% | Shares |
| SEVEN GRAND MANAGERS, LLC | $1,697,500 | 175,000 | 0.44% | Shares |
| STATE STREET CORP | $1,607,911 | 165,764 | 0.42% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,464,700 | 151,000 | 0.38% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,439,412 | 148,393 | 0.37% | Shares |
| ADAR1 Capital Management, LLC | $1,150,653 | 118,624 | 0.30% | Shares |
| Simplify Asset Management Inc. | $983,144 | 101,355 | 0.26% | Shares |
| VANGUARD GROUP INC | $890,973 | 207,686 | 0.23% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $824,500 | 85,000 | 0.21% | Shares |
| TWO SIGMA INVESTMENTS, LP | $762,178 | 78,575 | 0.20% | Shares |
| DAFNA Capital Management LLC | $650,880 | 67,101 | 0.17% | Shares |
| Quadrature Capital Ltd | $478,647 | 49,345 | 0.12% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $434,686 | 44,813 | 0.11% | Shares |
| XTX Topco Ltd | $412,337 | 42,509 | 0.11% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $301,796 | 31,113 | 0.08% | Shares |
| Velan Capital Investment Management LP | $242,500 | 25,000 | 0.06% | Shares |
| Atom Investors LP | $221,684 | 22,854 | 0.06% | Shares |
| BAILARD, INC. | $200,790 | 20,700 | 0.05% | Shares |
| Nuveen Asset Management, LLC | $187,599 | 18,611 | 0.05% | Shares |
| Spark Investment Management LLC | $160,050 | 16,500 | 0.04% | Shares |
| GOLDMAN SACHS GROUP INC | $153,066 | 15,780 | 0.04% | Shares |
| Squarepoint Ops LLC | $144,094 | 14,855 | 0.04% | Shares |
| ALLIANCEBERNSTEIN L.P. | $135,606 | 13,980 | 0.04% | Shares |
| Vanguard Global Advisers, LLC | $116,187 | 11,978 | 0.03% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $115,391 | 11,896 | 0.03% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $59,170 | 6,100 | 0.02% | Shares |
| Russell Investments Group, Ltd. | $53,263 | 5,491 | 0.01% | Shares |
| State of Wyoming | $44,504 | 4,588 | 0.01% | Shares |
| WELLS FARGO & COMPANY/MN | $38,606 | 3,980 | 0.01% | Shares |
| FMR LLC | $34,513 | 3,558 | 0.01% | Shares |
| RHUMBLINE ADVISERS | $29,474 | 3,039 | 0.01% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $20,719 | 2,136 | 0.01% | Shares |
| Federation des caisses Desjardins du Quebec | $19,400 | 2,000 | 0.01% | Shares |
| JPMORGAN CHASE & CO | $18,422 | 1,923 | 0.00% | Shares |
| CITIGROUP INC | $18,188 | 1,875 | 0.00% | Shares |
| China Universal Asset Management Co., Ltd. | $15,520 | 1,600 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $11,136 | 1,148 | 0.00% | Shares |
| NORTHERN TRUST CORP | $6,955 | 717 | 0.00% | Shares |
| BlackRock, Inc. | $5,781 | 596 | 0.00% | Shares |
| Legal & General Group Plc | $5,490 | 566 | 0.00% | Shares |
| Steward Partners Investment Advisory, LLC | $4,850 | 500 | 0.00% | Shares |
| BARCLAYS PLC | $4,792 | 494 | 0.00% | Shares |
| Ameritas Investment Partners, Inc. | $4,084 | 421 | 0.00% | Shares |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | $3,880 | 400 | 0.00% | Shares |
| Tower Research Capital LLC (TRC) | $2,396 | 247 | 0.00% | Shares |
| US BANCORP \DE\ | $2,280 | 235 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $2,000 | 224 | 0.00% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $1,940 | 200 | 0.00% | Shares |
| Quarry LP | $912 | 94 | 0.00% | Shares |
| Sterling Capital Management LLC | $698 | 72 | 0.00% | Shares |
| MORGAN STANLEY | $398 | 41 | 0.00% | Shares |
| ACADIAN ASSET MANAGEMENT LLC | $221 | 22,940 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $126 | 13 | 0.00% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $106 | 11 | 0.00% | Shares |
Company insiders 9 insiders · 8 officers · 2 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Fred Aslan | Chief Executive Officer | May 19, 2026 S | 1,535,082 | 0 | 3 | $-284,985 |
| Thad Allen Huston | Chief Financial Officer | March 10, 2026 A | 220,000 | 0 | 0 | $0 |
| Neha Krishnamohan | Chief Financial Officer | Nov. 15, 2025 F | 99,356 | 0 | 0 | $0 |
| Gines Diego Miralles | President & Head of R&D | May 18, 2026 A | 77,500 | 0 | 0 | $0 |
| Jennifer Bush | COO, CLO, Compliance Officer | May 19, 2026 S | 337,920 | 0 | 1 | $-79,198 |
| Subhashis Banerjee | Chief Medical Officer | May 19, 2026 S | 144,963 | 0 | 1 | $-63,403 |
| Heather Raymon | SVP, Research and Development | May 19, 2026 S | 148,228 | 0 | 1 | $-27,886 |
| Christopher Horan | Chief Tech Operations Officer | May 19, 2026 S | 293,450 | 0 | 1 | $-63,088 |
| Elaine K. Sorg | Director | Feb. 18, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 filings | July 23, 2026 | 37.90% | Amendment | — | SEC |
| GC Corp, GC Cell Corporation, Yong-Jun Huh | May 28, 2026 | 12.30% | Amendment | — | SEC |
| GC Corp., GC Cell Corporation, Yong-Jun Huh | July 29, 2024 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 11 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.01% | 15,784 SH | Aug. 8, 2026 | Daily |
| IWN · iShares Trust | 0.00% | 35,800 SH | Aug. 8, 2026 | Daily |
| IWM · iShares Trust | 0.00% | 137,793 SH | Aug. 8, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.00% | 3,029 NS | April 30, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 269,149 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 699,899 SH | Aug. 8, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 26,837 SH | Aug. 8, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,934 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,342 SH | Aug. 8, 2026 | Daily |
| IWO · iShares Trust | 0.00% | 176 SH | Aug. 8, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 678 NS | April 30, 2026 | N-PORT |